Community Practice Connections: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical Management
Webcast
Faculty
OVERVIEW
Community Practice Connections: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical Management is organized by Physicians Education Resource, LLC (PER) and will be held during Aug 31, 2017 - Aug 31, 2018.
The target audience for this medical event is directed toward community-based medical oncologists, surgical oncologists, and radiation oncologists interested in the treatment of CRPC. Nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with CRPC also are invited to participate. This CME Conference has been approved for a maximum of 1.5 AMA PRA Category 1 Credits.
Conference Overview :
Community Practice Connections: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical Management provides clinicians with an in-depth exploration of several clinical scenarios involving patients with metastatic prostate cancer, as well as a review of the latest literature that may help to guide treatment approaches for these patients. The text is accompanied by video interviews of leading experts in the treatment of patients with prostate cancer, who address questions commonly faced in the community oncology practice setting and provide their perspectives on recent data.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Describe how risk stratification and tumor information can guide sequencing in the management of castration-resistant prostate cancer (CRPC)
• Develop strategies to manage treatment-related side effects in patients with CRPC
• Evaluate recent practice-changing clinical trial findings concerning novel compounds or strategies to manage CRPC, including chemotherapeutic, hormonal, immunotherapeutic, and bone-directed approaches
• Apply emerging clinical concepts to create personalized treatment plans for the care of patients with CRPC
Additional details will be posted as soon as they are available.